Search Results - "Dold, Manuel Nico"

The deubiquitinase Usp27x as a novel regulator of cFLIPL protein expression and sensitizer to death-receptor-induced apoptosis by Dold, Manuel Nico, Ng, Xiulin, Alber, Claudia, Gentle, Ian Edward, Häcker, Georg, Weber, Arnim

“…Death receptors are transmembrane proteins that can induce the activation of caspase-8 upon ligand binding, initiating apoptosis. Recent work has highlighted…”
Get full text

Shaping a suitable EU HTA dossier template: why the German template is not fit for purpose by Schweitzer, Maria Katharina, Dold, Manuel Nico, Genet, Astrid, Gossens, Klaus, Klein-Hessling, Thomas, Löffler, Nils, Rabel, Matthias, Rasch, Andrej, Reuter, Eva-Maria, Schmelcher, Jessica, Wolfram, Natalia, Werner, Sebastian

“…From 2025, Health Technology Developers (HTDs) have to submit EU HTA dossiers. The joint clinical assessment (JCA) aims to streamline HTA processes and access…”
Get full text

The deubiquitinase Usp27x as a novel regulator of cFLIP L protein expression and sensitizer to death-receptor-induced apoptosis by Dold, Manuel Nico, Ng, Xiulin, Alber, Claudia, Gentle, Ian Edward, Häcker, Georg, Weber, Arnim

“…Death receptors are transmembrane proteins that can induce the activation of caspase-8 upon ligand binding, initiating apoptosis. Recent work has highlighted…”
Get full text

Auswirkungen der neuen Dossieranforderungen by Dr. rer. nat. Maria Katharina Schweitzer, Dr. rer. nat. Manuel Nico Dold, Dr. rer. nat. Astrid Genet, Klaus Gossens PhD, Dipl.-Math. Thomas Klein-Hessling, Nils Löffler MSc, Dr. phil. Matthias Rabel, Dr. PH Andrej Rasch, Jessica Schmelcher MSc, Dr. rer. nat. Sebastian Werner, Natalia Wolfram

“…Bei Markteintritt oder Zulassungserweiterung eines neuen Arzneimittels sind pharmazeutische Unternehmer in Deutschland seit 2011 zur Einreichung eines…”
Get full text